Melissa Hector-Greene
Melissa Hector-Greene
Verified email at duke.edu
Title
Cited by
Cited by
Year
The tumor suppressor PP2A Aβ regulates the RalA GTPase
AA Sablina, W Chen, JD Arroyo, L Corral, M Hector, SE Bulmer, ...
Cell 129 (5), 969-982, 2007
2202007
Identification of PP2A complexes and pathways involved in cell transformation
AA Sablina, M Hector, N Colpaert, WC Hahn
Cancer research 70 (24), 10474-10484, 2010
1782010
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A–mediated inactivation in human malignant glioma
P Puustinen, MR Junttila, S Vanhatupa, AA Sablina, ME Hector, ...
Cancer research 69 (7), 2870-2877, 2009
942009
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
BA Hanks, A Holtzhausen, KS Evans, R Jamieson, P Gimpel, ...
The Journal of clinical investigation 123 (9), 3925-3940, 2020
732020
Endoglin interacts with VEGFR2 to promote angiogenesis
H Tian, JJ Huang, C Golzio, X Gao, M Hector-Greene, N Katsanis, ...
The FASEB Journal 32 (6), 2934-2949, 2018
322018
TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling
K Tazat, M Hector-Greene, GC Blobe, YI Henis
Molecular biology of the cell 26 (19), 3535-3545, 2015
252015
Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin
L Pomeraniec, M Hector-Greene, M Ehrlich, GC Blobe, YI Henis
Molecular biology of the cell 26 (17), 3117-3127, 2015
252015
ALK1 Regulates the Internalization of Endoglin and the type III TGF-β Receptor
K Tazat, L Pomeraniec-Abudy, M Hector-Greene, SS Szilágyi, S Sharma, ...
Molecular Biology of the Cell, mbc. E20-03-0199, 2021
2021
Role of type III Transforming Growth Factor-ss receptor in regulating ALK1 signaling and endothelial biology
M Hector-Greene, K Tazat, Y Henis, G Blobe
ANGIOGENESIS 21 (1), 153-153, 2018
2018
The Role of Type III Transforming Growth Factor-β Receptor in Regulating ALK1
ME Hector-Greene
Duke University, 2017
2017
DALANTERCEPT ALK-1 ligand trap Prop INN; USAN Angiogenesis inhibitor Treatment of solid tumors
ME Hector-Greene, GC Blobe
DRUGS OF THE FUTURE 40 (10), 633-637, 2015
2015
The role of type III TGF-beta receptor in tumor angiogenesis
ME Hector-Greene, GC Blobe
ANGIOGENESIS 17 (4), 963-963, 2014
2014
Dalantercept. ALK-1 ligand trap, Angiogenesis inhibitor, treatment of solid tumors
ME Hector-Greene, GC Blobe
The system can't perform the operation now. Try again later.
Articles 1–13